🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
Study Aim is creation of the Hospital Register of patients with heart failu...
Status
Active Not Recruiting
Location
Moscow State Clinical Hospital named after V.V. Veresaev
Start Date
2023-09-01
Trial ID
NCT06114498
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
RATIONALE: ABT-510 may stop the growth of melanoma by blocking blood flow t...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00602199
Head and neck squamous cell carcinoma (HNSCC) represents a significant publ...
Status
Recruiting
Location
Bangabandhu Sheikh Mujib Medical University (BSMMU)
Start Date
2024-04-30
Trial ID
NCT06642324
Treatments Being Tested
RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT00550784
Colorectal cancer (CRC) is a global burden and one of the most frequent typ...
Status
Completed
Location
Hospital Universitario La Fe
Start Date
2018-05-04
Trial ID
NCT03601351
Treatments Being Tested
RATIONALE: Aurora A kinase inhibitor MLN8237 may stop the growth of tumor c...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2011-10
Trial ID
NCT01316692
Lymphedema, primary or secondary, is a chronic disease that causes function...
Status
Unknown
Location
Dept. of Maxillofacial Surgery, Azienda Ospedaliera Universitaria Senese
Start Date
2017-06-01
Trial ID
NCT03465930
Treatments Being Tested
RATIONALE: Riluzole may stop or slow the growth of tumor cells and may be a...
Status
Terminated
Location
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
Start Date
2007-02
Trial ID
NCT00667901